Jonathan Goldman
Director, Avalo Therapeutics, Inc.
Companies
- Avalo Therapeutics, Inc.Board member Apr 3, 2024 to now1
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Avalo Therapeutics, Inc. AVTX3,166 shares2$36.7K at $11.58Mar 28, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Mar 28, 2026Exercised options 3,166 shares of Avalo Therapeutics, Inc.2
- Nov 14, 2025Sold 8,200 shares at $14.35 of Avalo Therapeutics, Inc.3
- Nov 14, 2025Exercised options 8,200 shares at $9.88 of Avalo Therapeutics, Inc.3
- Nov 14, 2025Sold 3,167 shares at $14.30 of Avalo Therapeutics, Inc.3
- Mar 28, 2025Exercised options 3,167 shares of Avalo Therapeutics, Inc.4
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3SEC EDGARForm 4 filed Nov 17, 2025
- 4SEC EDGARForm 4 filed Apr 1, 2025